Development and Improvement of Home Rehabilitation Scheme for Preschool Children With Congenital Heart Disease After Operation
NCT ID: NCT07055334
Last Updated: 2025-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2025-07-10
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parent Communication for Feeding an Infant With a Heart Defect
NCT04452201
Brain Function in Children With Congenital Heart Disease (CHD)
NCT02814539
Executive Functions in Adults With Congenital Heart Disease
NCT04041557
Neonates With Neurological Complications
NCT00366561
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
NCT00713635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of congenital heart disease
* Underwent a single open-heart surgical correction under direct vision at the study site
* Ability to communicate in Chinese
* Primary caregiver who voluntarily provides care
* Caregiver who spends the most time with the child
* Ability to communicate in Chinese
* Licensed healthcare professionals, including physicians, nurses, dietitians, physical therapists, or psychological counselors
* At least 5 years of professional experience in congenital heart disease care, rehabilitation, or education
Exclusion Criteria
* Comorbid neurological, respiratory, or other systemic diseases
* Deemed unsuitable for exercise by a physician
* Cardiac function classified as NYHA Class IV
* Intellectual, language, or motor impairments resulting from perioperative complications or other causes
Caregivers of Children With Congenital Heart Disease After Surgery
* Caregivers of children who voluntarily discontinued treatment before completion
* Paid or professional caregivers
* Diagnosed cognitive impairment or mental illness
* Inability to communicate effectively through spoken language
* Presence of serious conflict or instability in the caregiver-child relationship
* Inability to independently operate or use smart electronic devices and the internet
Medical Professionals Involved in Congenital Heart Disease Care
* Not currently engaged in frontline clinical work
* Not engaged in clinical work within the past year due to leave, study, or reassignment
3 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wei XIA, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wei XIA, PhD
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xia Wei, PhD
Role: PRINCIPAL_INVESTIGATOR
Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSLL2024-801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.